What influences seniors' choice of medications for osteoarthritis? Qualitative inquiry

Canadian Family Physician

Volumn 52, Issue MAR., 2006, Pages 342-343

  Bower, Kelly Nicol ^a   Frail, Dawn ^b   Twohig, Peter L ^a,c   Putnam, Wayne ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Pharmaceutical Services   (Canada)

^c SAINT MARY S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; SIMVASTATIN;

AGED; ARTICLE; CANADA; CLINICAL ARTICLE; CONSUMER; DRUG COST; DRUG MARKETING; DRUG PREFERENCE; DRUG WITHDRAWAL; FEAR; GENERAL PRACTICE; GENERAL PRACTITIONER; GROUNDED THEORY; HOME; HUMAN; OSTEOARTHRITIS; PATIENT SELECTION; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; SIDE EFFECT;

ADVERTISING; AGED; CONSUMER PARTICIPATION; CYCLOOXYGENASE 2 INHIBITORS; DECISION MAKING; DRUG COSTS; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; OSTEOARTHRITIS; PHYSICIAN'S ROLE; PHYSICIANS, FAMILY;

EID: 33744469334     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kelsey JL. Epidemiology of chronic musculoskeletal disorders. Ann Rev Public Health 1988;9:379-401.
2. Mamdani M, Rochon P, Laupacis A, Anderson G. Initial patterns of use of COX2 inhibitors by elderly patients in Ontario: findings and implications, CMAJ 2002: 167: 1125-6.
3. Skedgel C. Drug use for Nova Scotia Pharmacare seniors: unpublished internal report prepared for Drug Evaluation Alliance of Nova Scotia. Halifax, NS: Nova Scotia Department of Health; 2002.
4. Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ 2002;325:619. Available from: http://bmj.bmjjournals.com/cgi/content/full/325/365/619. Accessed 2006 Jan 30.
5. Wright JM. The double-edged sword of COX-2 selective NSAIDS. CMAJ 2002;167:1131-7.
6. Braddock CH, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA 1999;282(24);2313 20.
7. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997;44(5)7681-92.
8. Elwyn G, Edwards A, Kinnersley P. Shared decision-making in primary care: the neglected second half of the consultation. Br J Gen Pract 1999;49:477-82.
9. Roter DL. Physician/patient communication: transmission of information and patient effects. Md State, Med J 1983;32(4):260-5.
10. Henderson S. Influences on patient participation and decision-making in care. Prof Nurse 2002; 17(9):521-5.
11. Lloyd AJ. The extent of patients' understanding of the risk of treatments. Qual Heath Care 2001; 10(Suppl 1):114-8.
12. Montgomery AA, Fahey T. How do patients' treatment preferences compare with those clinicians? Qual Health Care 2001;10(1):39-43.
13. Gurmankin AD, Baron J, Hershey JC, Ubel PA. The role of physicians' recommendations in medical treatment decisions. Med Decis Making 2002;22:262-71.
14. Gözüm S, Tezel A, Koc M. Complementary alternative treatments used by patients with cancer in eastern Turkey. Cancer Nurs 2003; 26(3):230-6.
15. Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross-sectional survey. BMJ 2002:3,24:278-9.
16. Fraenkel L, Wittink DR, Concato J, Fried T. Informed choice and the widespread use of antiinflammatory drugs. Arthritis Rheum 2004;51(2):210-4.
17. Bergström G, Bjelle A, Sorensen LB, Sundh V, Svanborg A. Prevalence of rheumatoid arthritis, osteoarthritis, chondrocalcinosis and gouty arthritis at age 79, J Rheumatol 1986;13(3):527-34.
18. Millar WJ. Multiple medication use among seniors. Health Rep 1998;9(4):11-7.
19. Torrible SJ, Hogan DB. Medication use and rural seniors; who really knows what they are taking? Can Fam Physician 1997;43:893-8.
20. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 2002;287(3):337-44.
21. Eisenberg DM, Davis RB. Ettner SL, Appel S, Wilkey S: Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA 1998:280(18):1569-75.
22. Patton MQ. Qualitative evaluation and research methods. Newbury Park, Calif: Sage Publications; 1990.
23. Lawson B, Putnam W, Nicol K, Frail D, Archibald G, MacKillop K, et al. Managing osteoarthritis. medication use among seniors in the community. Can Fam. Physician 2004;50:1664-70.
24. QSR International Pty Ltd. N5. Qualitative data analysis software for research professionals. Doncaster; Aust: QSR international Pty Ltd; 2000.
25. Chewing B, Sleath B. Medication decision-making and management: a client-centred model. Soc. Sci Med 1996;42:389-98.
26. Ford S, Schofield T, Hope T. Are patients' decision-making preferences being met? Health Expect 2003;6:72-80.
27. Charles CA, Whelan T, Gafni A, Willan A, Farrell S. Shared treatment decision making: what does it mean to physician? J Clin Oncol 2003;21(5);932-6.
28. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs consumer N Eng J Med 2002;346(7);498-505.
29. Groves KE, Sketris I, Tett SE. Prescription drug sample - does this marketing strategy counteract policies for quality use of medicines? J Clin Pharm Ther 2003;28:259-71
30. Kelly K, Vaida AJ. Free samples are not problem-free. Pharm Times 2003;69(1):22;26.
31. Schafheutle EI, Hassell K, Noyce PR, Weiss MC. Access to medicines: cost as an influence on the views and behaviour of patients. Health Soc Care Commun 2002; 10(3):187-95.